Consultations

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 15-16th March 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

Proposed amendments to the Poisons Standard. Closing date: 27 May 2022

The TGA is seeking feedback on a proposed priority pathway for assessment of certain novel and life-saving biologicals. Closing date: 28 March 2022

The Therapeutic Goods Administration (TGA) is seeking feedback on whether or not certain international scientific guidelines should be adopted.

The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2022-23 financial year. Closing date: 7 March 2022

The TGA is seeking feedback from sponsors on improving their access to medicine adverse event data. Closing date 18 February 2022

The TGA is seeking feedback on whether certain international scientific guidelines should be adopted. Closing date: 20 February 2022

Proposed amendments to the Poisons Standard. Closing date: 31 January 2022

The TGA is seeking feedback on a proposal to improve patient access to critical medicines in acute-care settings. Closing date: 7 February 2022

The TGA sought feedback on a Discussion paper on potential changes to mandatory reporting of medical device adverse events.

This consultation is for applications and delegate initiated proposals to amend the Poisons Standard. The scheduling amendments and any submissions received will be considered at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

The TGA is conducting a public consultation on potential options for the regulation of biologicals manufactured in Australia for export only (and not for supply in Australia). Closing date: 20 December 2021

This consultation is for interim decisions made in relation to applications to amend the Poisons Standard, following advice sought at the 3-4 November 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

This consultation is for interim decisions made in relation to applications to amend the Poisons Standard, following advice sought at the 3-4 November 2021 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS).

This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

The TGA is seeking feedback on the updated 'Listed medicines evidence guidelines - How to demonstrate efficacy of listed medicines'. Closing date: 1 April 2022

The outcome of the Listed medicines ingredient low-negligible risk changes 2021-22 have been published

Proposed amendments to the Poisons Standard. Closing date: 7 October 2021

Outcomes of the consultation and submissions received have now been published

Outcomes of the consultation and submissions received have now been published

Outcomes of the consultation and submissions received have now been published

The consultation period on changes to the assistive technologies exemption has been extended to 22 October 2021.

The public consultation for the Proposed refinements to the requirements for medical device patient information materials.

View the outcomes of public consultation on building a more robust medicine supply